中文 English

Investor Relations

Investor Relations

Corporate Governance

Board of Directors

Operating to global corporate governance standards, Porton’s Board of Directors is elected at the General Meeting of Shareholders. As the Company’s prime operational decision-making body, the Board of Directors always emphasizes rational and efficient decision-making mechanisms, collectively drawing on a rich body of experience gained in the pharmaceutical industry, law, investments, mergers and acquisitions, finance and accounting and , general management.

Board Committees
Board Member Strategy Audit Nominating Compensation & Appraisal
Lina HU
Guojun CAO
Nianfeng JU
Weiqiang YANG
Jinwei PANG
Ying XUE
Guohua CAO

Transparency. Sincerity. Efficiency. Innovation.

Board of Directors

Mr. Nianfeng JUChairman and CEO

Mr. Nianfeng JU is one of the co-founders of and De-Facto Controllers of Porton.

Mr.Yi LIPhD, Non-executive Director

Mr. Yi LI currently serves as the chairman and secretary of the CPC committee of Chongqing Liangjiang New Area Industrial Development Group Ltd. as well as the Chairman of the Management Committee of Chongqing Liangjiang Digital Economic Industrial Park.

Mr. Weiqiang YANGNon-executive Director

Mr. Weiqiang YANG currently is Chairman of Shenzhen Oriental Ruizhe Asset Management Co., Ltd. Most recently, Mr. Yang served as Chairman and President of Shenzhen Fosun Ruizhe Asset Management Co., Ltd. from 2014 to 2020. He used to serve as Senior Vice President and Executive Director in TCL Group, and managing partner of Heaven-Sent Capital Management Group Co., Ltd.

Ms. Ying XUENon-executive Director

Ms. Ying XUE has 17 years of experience in consulting. She currently serves as Director and General Manager of Mingxing Management Consulting (Shanghai) Co., Ltd., Executive Director of Haonan Management Consulting (Wuxi) Co., Ltd., and Partner of Shanghai Cuiwu Technology Co., Ltd.

Mr. Guojun CAOPh.D Non-executive Director

Mr. Guojun CAO, EMBA of Cheung Kong Graduate School of Business, Ph.D of Management, Senior Engineer, Researcher of CIO Research Center of Renmin University of China. He successively served as Deputy Head of Information Expert Leading Group of China National Pharmaceutical Group (Sinopharm Group), Deputy Director of Information Department of China National Pharmaceutical Group Co., Ltd., Party Branch Secretary and Deputy General Manager of Guangdong Paohe Chinese Herbal Medicine E-commerce Co., Ltd.

Ms. Lina HUNon-executive Director

Ms. Lina HU owns 5 national patents, participated in more than 50 new drug clinical trials of State Food and Drug Administration. She is currently a professor and Ph.D supervisor at the Second Affiliated Hospital of Chongqing Medical University, evaluation expert of new drugs and devices of State Food and Drug Administration, group member of recombinant humanized collagen standards of State Food and Drug Administration, Director of Chongqing Gynecological Medical Quality Control Center, Director of the Reproductive and Developmental Stem Cell Engineering Center of Chongqing Municipal Science and Technology Commission.

Ms. Lin YUANPhD, Independent Director

Ms. Lin YUAN is currently a professor and Ph.D supervisor of Law School of Southwest University of Political Science and Law, Director of Research Center for the Protection of Rights of Special Groups and Crime Prevention, Vice President of Chinese Society of Criminology, Director of China Banking Law Society. She also serves as Independent Director of Chongqing Yukaifa Co., Ltd., Chongqing Zhifei Biological Products Co., Ltd., and Jinke Smart Service Group Co., Ltd.

Mr.Guohua CAOPh.D Independent Director

Mr. Guohua CAO is currently a professor and Ph.D supervisor of School of Economics and Business Administration of Chongqing University, Independent Director of Jinke Smart Service Group Co., Ltd., Pingdingshan Oriental Carbon Co., Ltd., Director of Chongqing Tourism Investment Group Co., Ltd. and Chongqing Electromechanical Holding Group Xinbo Investment Management Co., Ltd.

Mr. Jinwei PANGPhD, Independent Director

Mr. Jinwei PANG is currently an associate professor in Shanghai National Accounting Institute, and serves as Independent Director in Shanghai DragonNet Technology Co.,Ltd., Shanghai Putailai New Energy Technology Co., Ltd., and Shanghai Hengye Microcrystalline Materials Technology Co., Ltd.

Legal Notices About Porton Investor Relations

Fangzheng Avenue, Shuitu, Beibei District, Chongqing, China.

Copyright © 2020 Porton Group. DIGITAL BY VTHINK


渝公网安备 50010902001378号